The Department of Veterans Affairs is seeking to procure Teriparatide Injection (250mcg/mL, 560mcg) in pen form through an unrestricted commercial item solicitation under FAR Part 12, with the goal of ensuring an uninterrupted supply for the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The solicitation, numbered 36E79726R0020, was posted on May 4, 2026, and responses are due by May 19, 2026, at 2:30 PM Central Time, submitted exclusively through SAM.gov. The contract structure includes a one-year base period with four additional one-year option periods, all pre-priced and exercisable at the government’s discretion. Offerors must supply the product with its exact labeled name and provide a unique National Drug Code (NDC) for each submission, with an estimated annual requirement of 39,038 pens. The place of performance is HINES, IL, with distribution managed through the VA and DOD Pharmaceutical Prime Vendor Programs. Award will be made to the responsible offeror capable of providing a continuous, reliable supply, with the approach aligning with a Lowest Price Technically Acceptable methodology, though not explicitly stated. The contracting office, located at the OPAL/National Acquisition Center in HINES, IL, is managed by Contract Specialist Billy Fong, who serves as the primary point of contact.
The acquisition is classified under NAICS code 325412 for Pharmaceutical Preparation Manufacturing, and the product must be FDA-approved and commercially available without modification. No specific packaging, labeling, inspection location, or FOB shipping terms are detailed in the solicitation, though compliance with federal labeling and NDC standards is required. There is no set-aside for small businesses or socioeconomic categories, and no representations, certifications, or socioeconomic declarations are required from offerors beyond standard SAM.gov registration. The solicitation does not include detailed evaluation factors, contract clauses, or attachments, and payment, invoicing, and accounting details such as appropriation codes or remittance instructions are not specified, although invoicing is expected to occur through the Pharmaceutical Prime Vendor Programs. The contracting office does not designate a separate COR/COTR or PCO beyond Billy Fong, and no additional special requirements, security clearances, or OCI provisions are included. Offerors must adhere to electronic submission protocols via SAM.gov without paper submissions permitted.
Department Of Veterans AffairsIL,
NAICS
325412
Pharmaceutical Preparation Manufacturing
PSC
6505
Medical, Dental, and Veterinary Equipment and Supplies
The Department of Veterans Affairs (VA) National Acquisition Center plans to issue Request for Proposal (RFP) 36E79726R0007 for the procurement of Nicotine Polacrilex Mini Lozenges intended to supply the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). This contract aims to establish a single responsible source capable of providing an uninterrupted supply of two dosage strengths—2mg and 4mg—of nicotine mini lozenges. The contract will have a base period of one year with four pre-priced one-year options exercisable at the government’s discretion, structured under the commercial item acquisition procedures in accordance with FAR Part 12. Distribution of the awarded products will occur through the VA and DOD Pharmaceutical Prime Vendor Programs, ensuring broad and efficient delivery to federal medical facilities nationwide.
The solicitation will be issued electronically on or about December 18, 2025, with proposals due by January 1, 2026, and will be available solely through the federal procurement website SAM.gov. Offerors must submit proposals electronically, supplying products labeled with the exact drug name as appears on the package and accompanied by a unique National Drug Code (NDC). Estimated annual quantities are approximately 166,791 bottles/cartons for the 2mg lozenge and 138,276 bottles/cartons for the 4mg lozenge, each packaged in units of 81. The solicitation does not specify pricing, evaluation factors, or detailed inspection and acceptance criteria beyond compliance with federal pharmaceutical and labeling standards. The contract administration, including invoicing and payment details, is undefined in the presolicitation, but the contracting officer specialist, Billy Fong, serves as the primary point of contact. No socioeconomic set-asides or special acquisition provisions require designation, indicating an open, unrestricted competition under NAICS code 325412 for pharmaceutical manufacturing.
Department Of Veterans AffairsIL,
USA$12.8Mest.
NAICS
325412
Pharmaceutical Preparation Manufacturing
PSC
6505
Medical, Dental, and Veterinary Equipment and Supplies
The contract involves the procurement of Simvastatin Tablets in multiple dosages and packaging configurations, intended for supply to the Department of Veterans Affairs and other federal agencies such as DOD, BOP, and IHS. The solicitation, issued by the VA National Acquisition Center, is structured as a Request for Quotation (RFQ) with a posting date of October 31, 2025, and a deadline for responses set for November 18, 2025, which was later extended to November 25, 2025. The procurement encompasses a base year plus four one-year option periods, with the contract to be awarded on an aggregate basis to the lowest evaluated price proposal that meets all technical and compliance standards. The NAICS code assigned is 325412, indicating a focus on pharmaceutical manufacturing.
Key technical requirements emphasize strict packaging, labeling, and stability standards. Packaging must utilize unit-of-use bottles with child-resistant safety caps, meet specific size and labeling dimensions, and incorporate barcodes compliant with GS1 or HIBCC standards, including encoding the National Drug Code (NDC), lot number, and expiration date. Labels must be free of overlays, and bottles must be glass-free, with stability testing ensuring product integrity during storage and transport. The contract clauses include standard FAR provisions related to labor standards, trafficking in persons, trade restrictions, and foreign acquisition limitations, with specific clauses addressing fair labor practices, wage adjustments, and trade compliance. The award process will prioritize the lowest price among proposals that satisfy all non-cost technical and compliance criteria, following a Lowest Price Technically Acceptable approach.
The solicitation also details administrative procedures for proposal submission, including electronic delivery via email, with no specified page limits but requiring a signed SF-1449 form and supporting documentation. Contract administration will involve designated points of contact for payment, oversight, and performance monitoring, with specific invoicing and reporting procedures to be clarified upon award. Overall, the contract aims to ensure a reliable supply of high-quality Simvastatin Tablets, adhering to rigorous packaging, labeling, and regulatory standards, with a focus on cost-effectiveness and compliance with federal acquisition regulations.
Department Of Veterans AffairsIL,
USA$16.8Mest.
NAICS
325412
Pharmaceutical Preparation Manufacturing
PSC
6505
Medical, Dental, and Veterinary Equipment and Supplies
The Department of Veterans Affairs, specifically through its NAC Pharmaceuticals office, has awarded a contract for the supply of Topiramate Tablets. The contract, with the solicitation number 36E79725R0031 and award number 36E79725D0045, was posted and awarded on June 26, 2025. XLCARE Pharmaceuticals Inc., located in Lawrenceville, Georgia, is the recipient of this contract, which has a total value of $14,134,788.05. The NAICS code associated with this award is 325412, indicating that it pertains to the pharmaceutical manufacturing industry, and the classification code is 6505, signifying drugs and biologicals.
The main point of contact for this contract is Billy Fong, a Contract Specialist, who can be reached by email at [email hidden] or by phone at [phone hidden]. The office responsible for this contract is located in Hines, Illinois. The contract remains active and is scheduled for automatic archival on August 25, 2025. The award notice and further details can be accessed through the SAM.gov portal. This award reinforces the ongoing efforts of the Department of Veterans Affairs to ensure the supply of critical pharmaceuticals to veterans across the United States.
Department Of Veterans AffairsIL,
USA$14.1Mest.
NAICS
325412
Pharmaceutical Preparation Manufacturing
PSC
6505
Medical, Dental, and Veterinary Equipment and Supplies
The Department of Veterans Affairs has awarded a significant contract, identified by number 36E79725D0031, for the supply of human insulin as part of its NAC Pharmaceuticals division. The award was made to SANOFI-AVENTIS U.S. LLC, a pharmaceutical company based in Bridgewater, New Jersey. The contract is valued at $465,370,525.50, indicating a large-scale procurement to support the healthcare needs of veterans. The NAICS code associated with this contract is 325412, which covers pharmaceutical preparation manufacturing, and the federal classification code is 6505, denoting medical and surgical instruments, equipment, and supplies.
The official award date for the contract is May 8, 2025, and the contract remains active. The primary point of contact is Billy Fong, a Contract Specialist for the Department of Veterans Affairs' office in Hines, Illinois. The contract notice was issued through the federal SAM.gov portal, and detailed information can be accessed online. This award highlights the Department's commitment to maintaining a steady supply of essential pharmaceuticals for veterans across the country through a major agreement with a leading supplier.
Department Of Veterans AffairsIL,
USA$465.4Mest.
NAICS
325412
Pharmaceutical Preparation Manufacturing
PSC
6505
Medical, Dental, and Veterinary Equipment and Supplies
The Department of Veterans Affairs, specifically through Nac Pharmaceuticals in Hines, Illinois, issued solicitation 36E79724R0033 for the procurement of Tadalafil Tablets under NAICS code 325412. During the solicitation process, an amendment was issued to extend the proposal due date from December 3, 2024, to December 10, 2024, at 2:30 PM CT, while maintaining all other original terms.
The contract was subsequently awarded to Solco Healthcare US LLC under award number 36E79725D0017 on February 20, 2025. The total award value is 12,938,537.60 dollars, with a defined period of performance running from April 21, 2025, through April 20, 2026. Billy Fong served as the Contract Specialist for this procurement.
Department Of Veterans AffairsIL,
USA$12.9Mest.
NAICS
325412
Pharmaceutical Preparation Manufacturing
PSC
6505
Medical, Dental, and Veterinary Equipment and Supplies
The Department of Veterans Affairs, specifically the Nac Pharmaceuticals office in Hines, Illinois, has awarded contract 36E79724D0022 to Golden State Medical Supply, Inc. for the procurement of Propranolol HCL Tablets. The total award value is 14,625,833.53 dollars, following solicitation 36E79724R0013 under NAICS code 325412.
The initial period of performance runs from August 11, 2024, through August 10, 2025. The agreement includes provisions for four additional one-year options to extend the contract. Billy Fong serves as the Contract Specialist for this award, which was officially finalized on May 13, 2024.
Department Of Veterans AffairsIL,
USA$14.6Mest.
NAICS
325412
Pharmaceutical Preparation Manufacturing
PSC
6505
Medical, Dental, and Veterinary Equipment and Supplies
The Department of Veterans Affairs National Acquisition Center awarded contract 36E79724D0020 to Golden State Medical Supply, Inc. for the supply of Mycophenolic Acid Enteric-coated Tablets. This unrestrictive procurement, conducted under NAICS code 325412, ensures an uninterrupted source of supply for the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The total award amount is 8,612,710.75 dollars, with an initial performance period effective from April 3, 2024, through April 2, 2025. The contract structure includes a base year with four pre-priced one-year option periods.
The scope of the agreement covers the delivery of Mycophenolic Acid in two strengths: 180mg tablets and 360mg tablets, both provided in 120-count bottles. Estimated annual requirements are 15,665 bottles of the 180mg strength and 23,916 bottles of the 360mg strength. Distribution of these pharmaceutical items is managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DOD. The procurement was managed by Contract Specialist Billy Fong and issued in commercial item format in accordance with FAR Part 12.
Department Of Veterans AffairsIL,
USA$8.6Mest.
NAICS
325412
Pharmaceutical Preparation Manufacturing
PSC
6505
Medical, Dental, and Veterinary Equipment and Supplies
This contract, identified by solicitation number 36E79723R0025 and award number 36E79724D0014, was issued by the Department of Veterans Affairs through Nac Pharmaceuticals in Hines, Illinois. The agreement was awarded to Exelan Pharmaceuticals Inc on January 17, 2024, for the procurement of Escitalopram Tablets. The total award value is $48,442,917.75, with a performance period effective from March 17, 2024, through March 16, 2025.
The procurement process included an amendment to extend the closing date to October 3, 2023, at 2:30 PM Central Time. The contract falls under NAICS code 325412 and was managed by Contract Specialist Billy Fong.
Department Of Veterans AffairsIL,
USA$48.4Mest.
NAICS
325412
Pharmaceutical Preparation Manufacturing
PSC
6505
Medical, Dental, and Veterinary Equipment and Supplies